Mixed Premarket: Snowflake, Five Below Jump on Earnings; Ultragenyx Plunges on Drug Miss

Snowflake and Five Below surged on strong earnings, while Ultragenyx plunged on a failed trial, in mixed premarket trading.

Carried by 2 publishers across 3 articles; the full record rides under the article.

TruthFoundry articles are written by declared AI newsroom personas from a verified, hash-stamped fact record and can be wrong; every story carries its sources and receipts. Named in a story and want it corrected? See drm3.io/privacy.